Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients
Background: Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma. Methods: Airway cells were obtained by sputum induction from 15 healthy and 39...
Saved in:
Published in | Thorax Vol. 61; no. 3; pp. 202 - 208 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd and British Thoracic Society
01.03.2006
BMJ BMJ Publishing Group LTD BMJ Group |
Subjects | |
Online Access | Get full text |
ISSN | 0040-6376 1468-3296 1468-3296 |
DOI | 10.1136/thx.2005.052399 |
Cover
Abstract | Background: Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma. Methods: Airway cells were obtained by sputum induction from 15 healthy and 39 asthmatic individuals and the airway T cell cytokine profiles (interleukin (IL)-4, IL-5, IL-13, IL-10 and interferon (IFN)-γ) at the mRNA level were studied by real time RT-PCR. Results: Asthma patients had increased expression of IL-5 (p = 0.001) and IL-13 (p = 0.03) mRNA in sputum compared with non-asthmatic controls. IL-4 mRNA and IFN-γ mRNA were detectable in the sputum of 44% and 21% of patients, respectively, but not in controls. Sputum IL-10 mRNA levels did not differ significantly between patients and controls. Sputum mRNA expression levels of IL-4, IL-5, and IL-13 were significantly correlated with the percentage of eosinophils and were higher in subjects with allergic asthma than in those with non-allergic asthma (p = 0.03, p = 0.02 and p = 0.0002, respectively); they did not differ between mild asthmatic subjects and those with moderate to severe asthma. In contrast, IFN-γ mRNA expression was higher in non-allergic than in allergic patients (p = 0.04) and higher in patients with moderate to severe asthma than in those with mild asthma (p<0.01). Sputum IL-5 mRNA levels (but not the other cytokine mRNA levels) were also correlated with exhaled nitric oxide (eNO) and with bronchial hyperreactivity expressed as the histamine concentration resulting in a 20% decrease in forced expiratory volume in 1 second. Conclusion: Real time RT-PCR analysis of mRNA in induced sputum confirms a predominance of Th2 cytokines in both allergic and non-allergic asthma. IL-5 levels reflect eosinophil infiltration as well as eNO levels and hyperreactivity, and levels of the Th1 cytokine IFN-γ indicate asthma severity. The technique is a promising tool for use in further studies of asthma severity and disease activity. |
---|---|
AbstractList | Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma.BACKGROUNDAsthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma.Airway cells were obtained by sputum induction from 15 healthy and 39 asthmatic individuals and the airway T cell cytokine profiles (interleukin (IL)-4, IL-5, IL-13, IL-10 and interferon (IFN)-gamma) at the mRNA level were studied by real time RT-PCR.METHODSAirway cells were obtained by sputum induction from 15 healthy and 39 asthmatic individuals and the airway T cell cytokine profiles (interleukin (IL)-4, IL-5, IL-13, IL-10 and interferon (IFN)-gamma) at the mRNA level were studied by real time RT-PCR.Asthma patients had increased expression of IL-5 (p = 0.001) and IL-13 (p = 0.03) mRNA in sputum compared with non-asthmatic controls. IL-4 mRNA and IFN-gamma mRNA were detectable in the sputum of 44% and 21% of patients, respectively, but not in controls. Sputum IL-10 mRNA levels did not differ significantly between patients and controls. Sputum mRNA expression levels of IL-4, IL-5, and IL-13 were significantly correlated with the percentage of eosinophils and were higher in subjects with allergic asthma than in those with non-allergic asthma (p = 0.03, p = 0.02 and p = 0.0002, respectively); they did not differ between mild asthmatic subjects and those with moderate to severe asthma. In contrast, IFN-gamma mRNA expression was higher in non-allergic than in allergic patients (p = 0.04) and higher in patients with moderate to severe asthma than in those with mild asthma (p<0.01). Sputum IL-5 mRNA levels (but not the other cytokine mRNA levels) were also correlated with exhaled nitric oxide (eNO) and with bronchial hyperreactivity expressed as the histamine concentration resulting in a 20% decrease in forced expiratory volume in 1 second.RESULTSAsthma patients had increased expression of IL-5 (p = 0.001) and IL-13 (p = 0.03) mRNA in sputum compared with non-asthmatic controls. IL-4 mRNA and IFN-gamma mRNA were detectable in the sputum of 44% and 21% of patients, respectively, but not in controls. Sputum IL-10 mRNA levels did not differ significantly between patients and controls. Sputum mRNA expression levels of IL-4, IL-5, and IL-13 were significantly correlated with the percentage of eosinophils and were higher in subjects with allergic asthma than in those with non-allergic asthma (p = 0.03, p = 0.02 and p = 0.0002, respectively); they did not differ between mild asthmatic subjects and those with moderate to severe asthma. In contrast, IFN-gamma mRNA expression was higher in non-allergic than in allergic patients (p = 0.04) and higher in patients with moderate to severe asthma than in those with mild asthma (p<0.01). Sputum IL-5 mRNA levels (but not the other cytokine mRNA levels) were also correlated with exhaled nitric oxide (eNO) and with bronchial hyperreactivity expressed as the histamine concentration resulting in a 20% decrease in forced expiratory volume in 1 second.Real time RT-PCR analysis of mRNA in induced sputum confirms a predominance of Th2 cytokines in both allergic and non-allergic asthma. IL-5 levels reflect eosinophil infiltration as well as eNO levels and hyperreactivity, and levels of the Th1 cytokine IFN-gamma indicate asthma severity. The technique is a promising tool for use in further studies of asthma severity and disease activity.CONCLUSIONReal time RT-PCR analysis of mRNA in induced sputum confirms a predominance of Th2 cytokines in both allergic and non-allergic asthma. IL-5 levels reflect eosinophil infiltration as well as eNO levels and hyperreactivity, and levels of the Th1 cytokine IFN-gamma indicate asthma severity. The technique is a promising tool for use in further studies of asthma severity and disease activity. BACKGROUND: Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma. METHODS: Airway cells were obtained by sputum induction from 15 healthy and 39 asthmatic individuals and the airway T cell cytokine profiles (interleukin (IL)-4, IL-5, IL-13, IL-10 and interferon (IFN)- gamma ) at the mRNA level were studied by real time RT-PCR. RESULTS: Asthma patients had increased expression of IL-5 (p = 0.001) and IL-13 (p = 0.03) mRNA in sputum compared with non-asthmatic controls. IL-4 mRNA and IFN- gamma mRNA were detectable in the sputum of 44% and 21% of patients, respectively, but not in controls. Sputum IL-10 mRNA levels did not differ significantly between patients and controls. Sputum mRNA expression levels of IL-4, IL-5, and IL-13 were significantly correlated with the percentage of eosinophils and were higher in subjects with allergic asthma than in those with non-allergic asthma (p = 0.03, p = 0.02 and p = 0.0002, respectively); they did not differ between mild asthmatic subjects and those with moderate to severe asthma. In contrast, IFN- gamma mRNA expression was higher in non-allergic than in allergic patients (p = 0.04) and higher in patients with moderate to severe asthma than in those with mild asthma (p<0.01). Sputum IL-5 mRNA levels (but not the other cytokine mRNA levels) were also correlated with exhaled nitric oxide (eNO) and with bronchial hyperreactivity expressed as the histamine concentration resulting in a 20% decrease in forced expiratory volume in 1 second. CONCLUSION: Real time RT-PCR analysis of mRNA in induced sputum confirms a predominance of Th2 cytokines in both allergic and non-allergic asthma. IL-5 levels reflect eosinophil infiltration as well as eNO levels and hyperreactivity, and levels of the Th1 cytokine IFN- gamma indicate asthma severity. The technique is a promising tool for use in further studies of asthma severity and disease activity. Background: Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma. Methods: Airway cells were obtained by sputum induction from 15 healthy and 39 asthmatic individuals and the airway T cell cytokine profiles (interleukin (IL)-4, IL-5, IL-13, IL-10 and interferon (IFN)-γ) at the mRNA level were studied by real time RT-PCR. Results: Asthma patients had increased expression of IL-5 (p = 0.001) and IL-13 (p = 0.03) mRNA in sputum compared with non-asthmatic controls. IL-4 mRNA and IFN-γ mRNA were detectable in the sputum of 44% and 21% of patients, respectively, but not in controls. Sputum IL-10 mRNA levels did not differ significantly between patients and controls. Sputum mRNA expression levels of IL-4, IL-5, and IL-13 were significantly correlated with the percentage of eosinophils and were higher in subjects with allergic asthma than in those with non-allergic asthma (p = 0.03, p = 0.02 and p = 0.0002, respectively); they did not differ between mild asthmatic subjects and those with moderate to severe asthma. In contrast, IFN-γ mRNA expression was higher in non-allergic than in allergic patients (p = 0.04) and higher in patients with moderate to severe asthma than in those with mild asthma (p<0.01). Sputum IL-5 mRNA levels (but not the other cytokine mRNA levels) were also correlated with exhaled nitric oxide (eNO) and with bronchial hyperreactivity expressed as the histamine concentration resulting in a 20% decrease in forced expiratory volume in 1 second. Conclusion: Real time RT-PCR analysis of mRNA in induced sputum confirms a predominance of Th2 cytokines in both allergic and non-allergic asthma. IL-5 levels reflect eosinophil infiltration as well as eNO levels and hyperreactivity, and levels of the Th1 cytokine IFN-γ indicate asthma severity. The technique is a promising tool for use in further studies of asthma severity and disease activity. Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma. Airway cells were obtained by sputum induction from 15 healthy and 39 asthmatic individuals and the airway T cell cytokine profiles (interleukin (IL)-4, IL-5, IL-13, IL-10 and interferon (IFN)-gamma) at the mRNA level were studied by real time RT-PCR. Asthma patients had increased expression of IL-5 (p = 0.001) and IL-13 (p = 0.03) mRNA in sputum compared with non-asthmatic controls. IL-4 mRNA and IFN-gamma mRNA were detectable in the sputum of 44% and 21% of patients, respectively, but not in controls. Sputum IL-10 mRNA levels did not differ significantly between patients and controls. Sputum mRNA expression levels of IL-4, IL-5, and IL-13 were significantly correlated with the percentage of eosinophils and were higher in subjects with allergic asthma than in those with non-allergic asthma (p = 0.03, p = 0.02 and p = 0.0002, respectively); they did not differ between mild asthmatic subjects and those with moderate to severe asthma. In contrast, IFN-gamma mRNA expression was higher in non-allergic than in allergic patients (p = 0.04) and higher in patients with moderate to severe asthma than in those with mild asthma (p<0.01). Sputum IL-5 mRNA levels (but not the other cytokine mRNA levels) were also correlated with exhaled nitric oxide (eNO) and with bronchial hyperreactivity expressed as the histamine concentration resulting in a 20% decrease in forced expiratory volume in 1 second. Real time RT-PCR analysis of mRNA in induced sputum confirms a predominance of Th2 cytokines in both allergic and non-allergic asthma. IL-5 levels reflect eosinophil infiltration as well as eNO levels and hyperreactivity, and levels of the Th1 cytokine IFN-gamma indicate asthma severity. The technique is a promising tool for use in further studies of asthma severity and disease activity. |
Author | Dilissen, E Dupont, L J Coteur, L Overbergh, L Bullens, D M A Truyen, E Ceuppens, J L |
AuthorAffiliation | E Truyen , L Coteur , E Dilissen , J L Ceuppens , D M A Bullens , Clinical Immunology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, (KULeuven), Leuven, Belgium L J Dupont , Pneumology, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium L Overbergh , Laboratory for Experimental Medicine and Endocrinology (LEGENDO), KULeuven, Leuven, Belgium D M A Bullens , Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium |
AuthorAffiliation_xml | – name: L Overbergh , Laboratory for Experimental Medicine and Endocrinology (LEGENDO), KULeuven, Leuven, Belgium – name: L J Dupont , Pneumology, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium – name: D M A Bullens , Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium – name: E Truyen , L Coteur , E Dilissen , J L Ceuppens , D M A Bullens , Clinical Immunology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, (KULeuven), Leuven, Belgium |
Author_xml | – sequence: 1 givenname: E surname: Truyen fullname: Truyen, E organization: Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium – sequence: 2 givenname: L surname: Coteur fullname: Coteur, L organization: Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium – sequence: 3 givenname: E surname: Dilissen fullname: Dilissen, E organization: Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium – sequence: 4 givenname: L surname: Overbergh fullname: Overbergh, L organization: Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium – sequence: 5 givenname: L J surname: Dupont fullname: Dupont, L J organization: Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium – sequence: 6 givenname: J L surname: Ceuppens fullname: Ceuppens, J L organization: Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium – sequence: 7 givenname: D M A surname: Bullens fullname: Bullens, D M A organization: Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17549450$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16449261$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc9v0zAYhi00xLbCmRuKhOCAlNaOfyUXpKlaGdIY0lS4Wl8ch7pLnCxOuvW_x10qCjvQk2X7eV99fnyOTlzjDEJvCZ4SQsWsXz1OE4z5FPOEZtkLdEaYSGOaZOIEnWHMcCyoFKfo3Ps1xjglRL5Cp0QwliWCnKH2cgPVAL1tXNSUEdjuAbaRdWUFdT0e59vofgDX2z7sNyZarshsuUoive2bO-tMVN_eXES1AT90pjauD_HIt0M_1E-Vvl_VELUhHO78a_SyhMqbN_t1gn4sLpfzq_j6-5ev84vrOBck62MDXBS5lJCloDVkMsG5SdOCUqmNwIUumC6IgTLNOcsTw4jUuYE0SynLdMHpBOGxd3AtbB-gqlTb2Rq6rSJY7eSpIE_t5KlRXoh8HiPtkNem0GHcDg6xBqz698bZlfrVbEJJiiXdFXzcF3TN_WB8r2rrtakqcKYZvBJSJpxycRQkkiSchakm6P0zcN0MnQviApMSKRIsWaDe_T344aH7bw7Ahz0AXkNVduC09QdOcpYxjgPHR053jfedKZV--vVm915b_cfc7FnuuOt4TFjfm8c_OHR3wRKVXN38nKvFlVjcZvSbWgb-08jn9fpo-W_yRPc8 |
CODEN | THORA7 |
CitedBy_id | crossref_primary_10_1016_j_jaci_2008_01_005 crossref_primary_10_1186_s12931_017_0524_y crossref_primary_10_1165_rcmb_2006_0252OC crossref_primary_10_1080_01902140802369372 crossref_primary_10_1186_1465_9921_10_3 crossref_primary_10_1038_nri2262 crossref_primary_10_1378_chest_11_1573 crossref_primary_10_1007_s11845_024_03695_5 crossref_primary_10_1111_cea_12125 crossref_primary_10_1016_j_rmed_2011_04_015 crossref_primary_10_1186_1868_7083_4_17 crossref_primary_10_1183_23120541_00280_2019 crossref_primary_10_1186_1471_2431_14_17 crossref_primary_10_4155_cli_15_38 crossref_primary_10_3390_ijms21207480 crossref_primary_10_1016_j_rmed_2017_10_004 crossref_primary_10_4049_jimmunol_1600007 crossref_primary_10_1016_S0140_6736_06_69290_8 crossref_primary_10_3390_atmos11010043 crossref_primary_10_1016_j_molimm_2022_01_005 crossref_primary_10_1080_15287394_2020_1806160 crossref_primary_10_1016_j_cyto_2021_155421 crossref_primary_10_2139_ssrn_4121000 crossref_primary_10_1111_j_1398_9995_2007_01545_x crossref_primary_10_1111_jpn_13114 crossref_primary_10_1016_j_prrv_2006_04_226 crossref_primary_10_1016_j_prrv_2016_02_002 crossref_primary_10_1164_rccm_201311_2011LE crossref_primary_10_1016_j_ejphar_2016_06_002 crossref_primary_10_1080_02770903_2016_1211142 crossref_primary_10_1165_rcmb_2009_0425OC crossref_primary_10_1016_j_bcp_2011_06_038 crossref_primary_10_3389_fmed_2017_00139 crossref_primary_10_1007_s11356_017_9907_3 crossref_primary_10_1186_1471_2466_9_34 crossref_primary_10_1016_j_biopha_2017_08_063 crossref_primary_10_1016_j_phrs_2009_10_003 crossref_primary_10_1042_CS20140309 crossref_primary_10_3390_cells11142238 crossref_primary_10_1097_MD_0000000000006265 crossref_primary_10_1111_all_15197 crossref_primary_10_1016_j_jaci_2016_03_010 crossref_primary_10_1172_JCI84144 crossref_primary_10_1155_2018_7253240 crossref_primary_10_1186_1472_6882_14_365 crossref_primary_10_1016_j_tox_2011_08_017 crossref_primary_10_1016_j_jaci_2013_07_036 crossref_primary_10_1016_j_jaci_2007_04_032 crossref_primary_10_3892_ijmm_2019_4322 crossref_primary_10_1155_2021_9621572 crossref_primary_10_1016_j_biopsycho_2009_10_005 crossref_primary_10_1111_cea_12220 crossref_primary_10_1016_j_intimp_2009_01_004 crossref_primary_10_1177_0394632015623794 crossref_primary_10_1016_j_intimp_2015_07_024 crossref_primary_10_1038_mi_2013_88 crossref_primary_10_1097_MCP_0000000000000345 crossref_primary_10_1038_nrdp_2015_25 crossref_primary_10_1111_ina_12656 crossref_primary_10_1089_pai_2006_19_135 crossref_primary_10_4049_jimmunol_0902287 crossref_primary_10_1097_WOX_0b013e31821188e0 crossref_primary_10_1186_s12931_021_01669_0 crossref_primary_10_3389_fimmu_2022_828690 crossref_primary_10_1016_j_humimm_2019_04_018 crossref_primary_10_1586_17476348_3_1_37 crossref_primary_10_4049_jimmunol_1501531 crossref_primary_10_1016_j_jaci_2010_08_008 crossref_primary_10_4168_aair_2011_3_1_11 crossref_primary_10_1183_13993003_00644_2018 crossref_primary_10_1016_S0140_6736_06_69288_X crossref_primary_10_1186_1465_9921_7_135 crossref_primary_10_1097_MCP_0b013e32831da867 crossref_primary_10_1016_j_jaci_2016_04_063 crossref_primary_10_3390_ijms20122980 crossref_primary_10_1016_j_pupt_2010_06_006 crossref_primary_10_4049_jimmunol_1002027 crossref_primary_10_1111_j_1365_2222_2009_03383_x crossref_primary_10_3390_jcm8101615 crossref_primary_10_3923_mj_2015_49_57 crossref_primary_10_1136_thorax_2022_219651 crossref_primary_10_1111_all_12540 crossref_primary_10_1111_j_1365_2222_2008_03135_x crossref_primary_10_3390_ijms24087581 crossref_primary_10_1016_j_taap_2013_08_015 crossref_primary_10_1097_MCP_0b013e3280108757 crossref_primary_10_1111_cea_12729 crossref_primary_10_1016_j_jaci_2019_07_014 crossref_primary_10_3390_biomedicines10092311 crossref_primary_10_1186_1465_9921_12_2 crossref_primary_10_1378_chest_07_1881 crossref_primary_10_1002_eji_200838463 crossref_primary_10_1111_j_1365_2222_2008_03045_x crossref_primary_10_1164_rccm_202402_0403OC crossref_primary_10_1016_j_bbi_2020_08_003 crossref_primary_10_1111_j_1365_3083_2008_02098_x crossref_primary_10_1080_13543784_2018_1427729 crossref_primary_10_3390_ijms232314909 crossref_primary_10_1111_aji_13486 crossref_primary_10_1016_j_bbi_2024_07_038 crossref_primary_10_1186_1465_9921_14_34 crossref_primary_10_1016_j_jaci_2012_09_028 crossref_primary_10_1016_j_rmed_2012_11_003 crossref_primary_10_1186_s41043_024_00541_3 crossref_primary_10_1016_j_jaci_2015_02_039 crossref_primary_10_1111_bcp_12508 crossref_primary_10_1371_journal_pone_0171047 crossref_primary_10_1016_j_anai_2012_12_026 crossref_primary_10_1007_s00011_012_0538_3 crossref_primary_10_1002_lary_24590 crossref_primary_10_1513_AnnalsATS_201507_431MG crossref_primary_10_1016_j_arbres_2010_04_010 crossref_primary_10_4168_aair_2010_2_2_134 crossref_primary_10_1172_jci_insight_91019 crossref_primary_10_1111_j_1440_1843_2011_02021_x crossref_primary_10_1016_j_jaci_2012_06_025 crossref_primary_10_1111_j_1398_9995_2007_01550_x crossref_primary_10_1111_j_1365_2222_2009_03384_x crossref_primary_10_1016_S0300_2896_11_70002_3 crossref_primary_10_1016_j_ejphar_2017_07_033 crossref_primary_10_1016_j_jaci_2008_07_010 crossref_primary_10_1016_S1579_2129_10_70113_0 crossref_primary_10_1113_JP284686 crossref_primary_10_1111_all_13136 crossref_primary_10_2353_ajpath_2009_071151 crossref_primary_10_36691_RJA1025 crossref_primary_10_1080_08958378_2016_1175526 crossref_primary_10_1111_cea_12389 crossref_primary_10_1111_resp_12219 crossref_primary_10_3109_02770903_2010_489245 crossref_primary_10_3390_molecules27207028 crossref_primary_10_1016_j_cyto_2010_09_011 crossref_primary_10_3390_cells11172686 crossref_primary_10_4168_aair_2014_6_3_189 crossref_primary_10_1016_j_pharmthera_2016_10_010 crossref_primary_10_1111_j_1398_9995_2009_02156_x crossref_primary_10_1111_nyas_12357 crossref_primary_10_3390_biom11081084 crossref_primary_10_1111_j_1365_2222_2008_02971_x crossref_primary_10_3389_fimmu_2019_00840 crossref_primary_10_3390_ijerph18179283 crossref_primary_10_1080_02770900802604111 crossref_primary_10_1186_1465_9921_11_177 crossref_primary_10_1038_s41591_019_0468_5 crossref_primary_10_1177_1559325820982189 crossref_primary_10_1097_ACI_0000000000000497 crossref_primary_10_3389_fphar_2019_01387 |
ContentType | Journal Article |
Copyright | Copyright 2006 Thorax 2006 INIST-CNRS Copyright: 2006 Copyright 2006 Thorax Copyright © 2006 BMJ Publishing Group and British Thoracic Society |
Copyright_xml | – notice: Copyright 2006 Thorax – notice: 2006 INIST-CNRS – notice: Copyright: 2006 Copyright 2006 Thorax – notice: Copyright © 2006 BMJ Publishing Group and British Thoracic Society |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7T5 7TM H94 7X8 5PM ADTOC UNPAY |
DOI | 10.1136/thx.2005.052399 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central BMJ Journals ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) BMJ Journals Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) AIDS and Cancer Research Abstracts Immunology Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts ProQuest One Academic Middle East (New) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-3296 |
EndPage | 208 |
ExternalDocumentID | 10.1136/thx.2005.052399 PMC2080739 4026848081 16449261 17549450 10_1136_thx_2005_052399 ark_67375_NVC_FH6FR93M_T thoraxjnl |
Genre | Evaluation Studies Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Belgium United States--US Europe |
GeographicLocations_xml | – name: United States--US – name: Europe – name: Belgium |
GroupedDBID | --- .55 .GJ .VT 08G 0R~ 123 18M 29Q 2WC 354 39C 3O- 4.4 40O 53G 5RE 5VS 6PF 7X7 7~S 88E 8F7 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN AAWTL AAYEP ABAAH ABJNI ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGTL ACHTP ACMFJ ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN BAWUL BENPR BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C45 CAG CCPQU COF CS3 CXRWF DIK DU5 E3Z EBS EJD F5P FEDTE FYUFA GX1 H13 HAJ HMCUK HVGLF HYE HZ~ IAO IEA IH2 IHR IOF ITC J5H KQ8 L7B M1P N4W N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UAW UKHRP UYXKK V24 VM9 VVN W8F WH7 X7M YFH YOC YQY ZCG ZGI 3V. BSCLL RHF AAYXX ACQHZ ADGHP AERUA CITATION PHGZM PJZUB PPXIY PUEGO IQODW CGR CUY CVF ECM EIF NPM PKN 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7T5 7TM H94 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-b619t-ea56db77a98acca9720be88d337ce60dcd4cd1eaf8b54b2e417cbea898349cd53 |
IEDL.DBID | 7X7 |
ISSN | 0040-6376 1468-3296 |
IngestDate | Wed Oct 01 16:30:06 EDT 2025 Tue Sep 30 16:42:14 EDT 2025 Fri Sep 05 01:17:35 EDT 2025 Wed Oct 01 13:39:48 EDT 2025 Sat Aug 23 14:59:45 EDT 2025 Wed Feb 19 01:43:28 EST 2025 Mon Jul 21 09:12:04 EDT 2025 Wed Oct 01 00:59:08 EDT 2025 Thu Apr 24 23:05:39 EDT 2025 Wed Oct 30 10:00:29 EDT 2024 Thu Apr 24 23:05:33 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Human Measurement Lung disease Evaluation Respiratory disease Cytokine Th1 lymphocyte Cardiovascular disease Patient Inflammation Asthma Messenger RNA Immunological investigation Sputum T-Lymphocyte Bronchus disease Th2 lymphocyte Obstructive pulmonary disease Quantitative analysis |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b619t-ea56db77a98acca9720be88d337ce60dcd4cd1eaf8b54b2e417cbea898349cd53 |
Notes | PMID:16449261 href:thoraxjnl-61-202.pdf Correspondence to: Dr D M A Bullens Clinical Immunology, University Hospital, Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium; Dominique.Bullens@med.kuleuven.be ark:/67375/NVC-FH6FR93M-T istex:7CDEB2A5D60BE052C0486ED83A59AFAFCC06859E local:0610202 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://thorax.bmj.com/content/thoraxjnl/61/3/202.full.pdf |
PMID | 16449261 |
PQID | 1781762074 |
PQPubID | 2041050 |
PageCount | 7 |
ParticipantIDs | unpaywall_primary_10_1136_thx_2005_052399 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2080739 proquest_miscellaneous_67725356 proquest_miscellaneous_17125452 proquest_journals_1781762074 pubmed_primary_16449261 pascalfrancis_primary_17549450 crossref_citationtrail_10_1136_thx_2005_052399 crossref_primary_10_1136_thx_2005_052399 istex_primary_ark_67375_NVC_FH6FR93M_T bmj_primary_10_1136_thx_2005_052399 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-03-01 |
PublicationDateYYYYMMDD | 2006-03-01 |
PublicationDate_xml | – month: 03 year: 2006 text: 2006-03-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Thorax |
PublicationTitleAlternate | Thorax |
PublicationYear | 2006 |
Publisher | BMJ Publishing Group Ltd and British Thoracic Society BMJ BMJ Publishing Group LTD BMJ Group |
Publisher_xml | – name: BMJ Publishing Group Ltd and British Thoracic Society – name: BMJ – name: BMJ Publishing Group LTD – name: BMJ Group |
References | 15502111 - Am J Respir Crit Care Med. 2005 Feb 1;171(3):224-30 9392697 - N Engl J Med. 1997 Dec 11;337(24):1720-5 10529782 - Immunol Today. 1999 Nov;20(11):528-33 15131568 - J Allergy Clin Immunol. 2004 May;113(5):868-75 9916129 - J Clin Invest. 1999 Jan;103(2):175-83 8912771 - Am J Respir Crit Care Med. 1996 Nov;154(5):1497-504 9117015 - Am J Respir Crit Care Med. 1997 Mar;155(3):845-51 8804934 - Eur Respir J. 1996 Jun;9(6):1174-80 11172168 - N Engl J Med. 2001 Feb 1;344(5):350-62 10358759 - Annu Rev Immunol. 1999;17:255-81 10629459 - J Allergy Clin Immunol. 2000 Jan;105(1 Pt 1):99-107 9624291 - Thorax. 1998 Feb;53(2):91-5 9309982 - Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):704-8 8648025 - J Allergy Clin Immunol. 1996 Jun;97(6):1288-96 9155833 - J Allergy Clin Immunol. 1997 May;99(5):657-65 8630259 - Am J Respir Cell Mol Biol. 1996 Feb;14(2):113-7 9155837 - J Allergy Clin Immunol. 1997 May;99(5):693-8 7491549 - Thorax. 1995 Oct;50(10):1033-7 9661676 - J Asthma. 1998;35(3):243-9 11496235 - J Allergy Clin Immunol. 2001 Aug;108(2):205-11 1626792 - Am Rev Respir Dis. 1992 Jul;146(1):109-15 15113433 - BMC Pulm Med. 2004 Mar 17;4:2 14674929 - Allergy. 2004 Jan;59(1):26-32 11112154 - Am J Respir Crit Care Med. 2000 Dec;162(6):2295-301 9949314 - J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):238-45 15375256 - Science. 2004 Sep 17;305(5691):1726-9 7695062 - Allergy. 1994 Oct;49(9):730-6 10573240 - Eur Respir J. 1999 Oct;14(4):902-7 11122208 - Clin Exp Allergy. 2000 Dec;30(12):1709-16 11846608 - Methods. 2001 Dec;25(4):386-401 11591195 - Clin Exp Allergy. 2001 Sep;31(9):1441-8 15775993 - Nat Rev Immunol. 2005 Apr;5(4):271-83 10325905 - Thorax. 1999 Mar;54(3):268-72 9517608 - Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):894-8 15328669 - Ann Allergy Asthma Immunol. 2004 Aug;93(2):112-22; quiz 122-4, 184 |
References_xml | – reference: 11846608 - Methods. 2001 Dec;25(4):386-401 – reference: 9517608 - Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):894-8 – reference: 10629459 - J Allergy Clin Immunol. 2000 Jan;105(1 Pt 1):99-107 – reference: 10573240 - Eur Respir J. 1999 Oct;14(4):902-7 – reference: 9309982 - Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):704-8 – reference: 9392697 - N Engl J Med. 1997 Dec 11;337(24):1720-5 – reference: 15328669 - Ann Allergy Asthma Immunol. 2004 Aug;93(2):112-22; quiz 122-4, 184 – reference: 9117015 - Am J Respir Crit Care Med. 1997 Mar;155(3):845-51 – reference: 7491549 - Thorax. 1995 Oct;50(10):1033-7 – reference: 8648025 - J Allergy Clin Immunol. 1996 Jun;97(6):1288-96 – reference: 8804934 - Eur Respir J. 1996 Jun;9(6):1174-80 – reference: 9949314 - J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):238-45 – reference: 8630259 - Am J Respir Cell Mol Biol. 1996 Feb;14(2):113-7 – reference: 10325905 - Thorax. 1999 Mar;54(3):268-72 – reference: 14674929 - Allergy. 2004 Jan;59(1):26-32 – reference: 10529782 - Immunol Today. 1999 Nov;20(11):528-33 – reference: 8912771 - Am J Respir Crit Care Med. 1996 Nov;154(5):1497-504 – reference: 11172168 - N Engl J Med. 2001 Feb 1;344(5):350-62 – reference: 11112154 - Am J Respir Crit Care Med. 2000 Dec;162(6):2295-301 – reference: 15113433 - BMC Pulm Med. 2004 Mar 17;4:2 – reference: 9661676 - J Asthma. 1998;35(3):243-9 – reference: 7695062 - Allergy. 1994 Oct;49(9):730-6 – reference: 11591195 - Clin Exp Allergy. 2001 Sep;31(9):1441-8 – reference: 11496235 - J Allergy Clin Immunol. 2001 Aug;108(2):205-11 – reference: 15131568 - J Allergy Clin Immunol. 2004 May;113(5):868-75 – reference: 1626792 - Am Rev Respir Dis. 1992 Jul;146(1):109-15 – reference: 15375256 - Science. 2004 Sep 17;305(5691):1726-9 – reference: 15775993 - Nat Rev Immunol. 2005 Apr;5(4):271-83 – reference: 9155837 - J Allergy Clin Immunol. 1997 May;99(5):693-8 – reference: 10358759 - Annu Rev Immunol. 1999;17:255-81 – reference: 9916129 - J Clin Invest. 1999 Jan;103(2):175-83 – reference: 9624291 - Thorax. 1998 Feb;53(2):91-5 – reference: 11122208 - Clin Exp Allergy. 2000 Dec;30(12):1709-16 – reference: 9155833 - J Allergy Clin Immunol. 1997 May;99(5):657-65 – reference: 15502111 - Am J Respir Crit Care Med. 2005 Feb 1;171(3):224-30 |
SSID | ssj0008117 |
Score | 2.2702591 |
Snippet | Background: Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in... Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in the... BACKGROUND: Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in... |
SourceID | unpaywall pubmedcentral proquest pubmed pascalfrancis crossref istex bmj |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 202 |
SubjectTerms | Adolescent Adult Aged Allergens Allergies ASS Asthma Asthma - metabolism Asthma - physiopathology asthma symptom score Biological and medical sciences Bronchitis - diagnosis Cells Chemokines Chronic obstructive pulmonary disease, asthma Cytokines Cytokines - metabolism eNO exhaled nitric oxide Female FEV1 Forced Expiratory Volume - physiology forced expiratory volume in 1 second histamine concentration provoking a 20% decrease in FEV1 Humans ICS IFN-γ induced sputum Inflammation inhaled corticosteroids interferon γ interleukin mAb Male Medical sciences messenger RNA Middle Aged monoclonal antibody mRNA Patients PC20 Pneumology Reverse Transcriptase Polymerase Chain Reaction - methods RNA, Messenger - metabolism severity Sputum - metabolism T helper Th1 Cells - metabolism Th1/Th2 cytokines Th2 Cells - metabolism |
SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeglYAXvj8CY1gCIXhI2sSxEz9W06oKqRWaWjTEQ2Q7jrK1TUubaC1_PeckTSkwTfAany_K-XIf9t3PCL0TUhCqlWvrONG2LwixhfQVGMOEE0mE7pYnpsMRG0z8T-f0vK6qNL0weQpfvnHk_LJqaDAQTVleP77MZh3mdojJ2B2zPe0s4-Q2ajNzuNRC7cnoc-_rrkyOkaBpLSIeZzWuj0sYcNvUuynUtHaCW4H3HTimtpHxxhRKijXIKqkuufhbFPpnMeXdIluK7ZWYzX7xVP0H6NvuG6sClalT5NJRP36Df_w_ITxE9-sAFvcqjXuEbunsMbozrI_on6DlaYMfjhcJFherK7HFoMegelWbJJZb_L0QWdneBsYWj1O3M049rLb5YgpM8Pxs1MPz_e4lTMfrZZEX85LlOk_nAteIsOunaNI_HZ8M7PpaB1tCtpbbWlAWyyAQPBSgPzzwulKHYUxIoDTrxir2VexqkYSS-tLTvhsoqUXIQ-JzFVPyDLWyRaZfICy4BCff1Upz8LIhk5QI7vNYJJ4yxbsWegtCjJYVcEdUJjyERbD-5vpNGlXrbyFnt_KRqpHRzQUds-snfGgm3Mj7falKDZ1YTU0tXUCj0ZeTqD9g_TNOhtHYQscHurZnHEAK79OuhY52yhfVdmYNg6EL7gziQAu9aYbBQphjH5HpRWFoIIj1qXc9BYMUixIK4npe6fL-5RAuc0iyLRQcaHlDYNDJD0eyi7REKfcgFwkICOBj8z_cJKyX_0D7Ct2rdsNMOeARauWrQr-G-DCXx7Uh-AlvtGZN priority: 102 providerName: Unpaywall |
Title | Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients |
URI | https://thorax.bmj.com/content/61/3/202.full https://api.istex.fr/ark:/67375/NVC-FH6FR93M-T/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/16449261 https://www.proquest.com/docview/1781762074 https://www.proquest.com/docview/17125452 https://www.proquest.com/docview/67725356 https://pubmed.ncbi.nlm.nih.gov/PMC2080739 https://thorax.bmj.com/content/thoraxjnl/61/3/202.full.pdf |
UnpaywallVersion | publishedVersion |
Volume | 61 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1468-3296 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0008117 issn: 1468-3296 databaseCode: KQ8 dateStart: 19460301 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1468-3296 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0008117 issn: 1468-3296 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1468-3296 dateEnd: 20071231 omitProxy: true ssIdentifier: ssj0008117 issn: 1468-3296 databaseCode: RPM dateStart: 19460101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1468-3296 dateEnd: 20250402 omitProxy: true ssIdentifier: ssj0008117 issn: 1468-3296 databaseCode: BENPR dateStart: 19460301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1468-3296 dateEnd: 20250402 omitProxy: true ssIdentifier: ssj0008117 issn: 1468-3296 databaseCode: 7X7 dateStart: 19460301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdglWAviG8yRrEEQvAQmsRxEj-hMrVUSK2mqkXlKbIdRx1r065JtPW_55y4KRWMPUaxHeXu5_vy-Q6h91xwQpV0bZWkyvY5ITYXvgRhmDIiCFdOdWI6HAWDqf99Rmcm4JabtMqdTKwEdbKSOkbeccPIhY0LGu_L-srWXaP06appoXEftVwwVTSqw1njcDn6EuUuay6AnWRK-7gk6BTzGxNQofp2J2gWsfx1oJtamsw3OleS50CutO5z8S9D9O98yodltubba75Y_KGs-o_RI2Nl4m4NiyfonsqeogdDc47-DK17TZFvvEoxv9hc8y0GsAE-6ruMWGzxVcmz6g4aSEQ8mbudydzDclusLmERvByPuni5DzHCdJyvy6JcVkvmxXzJsSnbmj9H035vcjawTe8FW4BLVdiK0yARYchZxIHJLPQcoaIoISSUKnASmfgycRVPI0F94SnfDaVQPGIR8ZlMKHmBjrJVpl4hzJkATewoqRiowigQlHDms4SnntQZthZ6B7SP13V1jbjySkgQA4d0j0wa1xyy0Ocdb2JpypfrLhqL2yd8bCbcufaHitnNOL651AlvIY1HP87i_iDojxkZxhMLtQ_QsF84BD_bp46FTnfwiI0wyOM9dC30tnkN21ifzfBMrUo9BixNn3q3jwjAD6KEArle1mjbfxxsWgaesIXCAxw2A3QJ8cM32cW8KiXugcMQEiDApwaxdxHr5P-_-Bod11EqnaZ3io6KTanegN1WiHa1Oduo9bU3Oh_D07eZC0_T0Xn3528hIUah |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTWK8IO4ExmaJi-AhNIntXB4Qmsaqjq19mDq0N2M7jjrWpl2TqOuf4jdynFupYOxpz7GdxOfzuflcEHorpCBMK9fWcaJtKgixhaQKmGESEUmEdsob0_7A753Rb-fsfAP9anJhTFhlwxNLRh1PlfGRd9wgdOHggsT7MruyTdcoc7vatNCoYHGslwsw2bLPR1-Bvu88r3s4POjZdVcBW4KxkNtaMD-WQSCiUMDnR4HnSB2GMSGB0r4Tq5iq2NUiCSWj0tPUDZTUIoxCQiMVmy4RwPK3KHGoqdUfnLcGnmOSNpsoPR9Obl1KyCV-Jx9d1w4cZrJJQZLJyc81WbhlyHptYjNFBuRJqr4a_1J8_47f3C7SmVguxHj8h3DsPkQPaq0W71cwfIQ2dPoY3evX9_ZP0OywLSqOpwkWF_OFWGIAN-Cxyp3EcomvCpGWOW_AgfFw5HaGIw-rZT69hEXw5HSwjycrlyZMx9msyItJuWSWjyYC12Vis6fo7E6o8gxtptNUv0BYRBIkv6OVjkD0hr5kREQ0ikXiKRPRa6E3sPd8VlXz4KUVRHwOFDI9ORmvKGShTw1tuKrLpZuuHeObJ3xoJ9y69vuS2O04Mb80AXYB44PvB7zb87unEenzoYV219CwWjgAu54yx0I7DTx4zXwyvjoqFtprHwPbMHdBItXTwowBzZYy7-YRPthdjDDYrucV2lYvBx06AsvbQsEaDtsBpmT5-pP0YlSWLvfAQAkIbMDHFrG3bdbL___iHtruDfsn_ORocPwK3a88ZCZEcAdt5vNCvwadMZe75UHF6Mddc4bfhsaByA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTRq8IO4ExmaJi-AhNInjOHlAaNpWdYxWaOpQ3zLbcZSxNu2aRF3_Gr-O49xKBWNPe_Ylis_xd87xuSH0lgtOqJK2qaJYmS4nxOTClQCGcUAE4coqPab9gdc7c7-O6GgD_WpyYXRYZYOJJVBHU6nfyDs28224uCDxOnEdFvH9sPtldmXqDlLa09q006hY5EQtF2C-ZZ-PD4HW7xynezQ86Jl1hwFTgOGQm4pTLxKM8cDn8CsBcyyhfD8ihEnlWZGMXBnZise-oK5wlGszKRT3A5-4gYx0xwiA_y1GXKLDydioNfYsncDZROx5cIvrskI28Tp5cl0_5lCdWQpSTUx-rsnFLU3iax2nyTMgVVz12PiXEvx3LOe9Ip3x5YKPx38Iyu5D9KDWcPF-xZKP0IZKH6Ptfu3Df4JmR22BcTyNMb-YL_gSA6MDb1Z5lFgs8VXB0zL_DdAYDxO7M0wcLJf59BI2wZPTwT6erJ43YTnOZkVeTMotszyZcFyXjM2eorM7ocoztJlOU_UCYR4I0AIsJVUAYtj3BCU8cIOIx47U0b0GegNnH86qyh5haRERLwQK6f6cNKwoZKBPDW1CWZdO1x08xjcv-NAuuHXv9yWx23l8fqmD7RgNBz8Owm7P654GpB8ODbS7xg2rjRnY-C61DLTTsEdYA1EWrq6NgfbaYYAQ7RfiqZoWeg5ouS51bp7hgQ1GCYXjel5x2-rjoE8HYIUbiK3xYTtBly9fH0kvkrKMuQPGCiNwAB9bjr3tsF7-_xf30DZgQvjteHDyCt2vHst0tOAO2sznhXoN6mMudst7itH5XQPDb5OZhgM |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeglYAXvj8CY1gCIXhI2sSxEz9W06oKqRWaWjTEQ2Q7jrK1TUubaC1_PeckTSkwTfAany_K-XIf9t3PCL0TUhCqlWvrONG2LwixhfQVGMOEE0mE7pYnpsMRG0z8T-f0vK6qNL0weQpfvnHk_LJqaDAQTVleP77MZh3mdojJ2B2zPe0s4-Q2ajNzuNRC7cnoc-_rrkyOkaBpLSIeZzWuj0sYcNvUuynUtHaCW4H3HTimtpHxxhRKijXIKqkuufhbFPpnMeXdIluK7ZWYzX7xVP0H6NvuG6sClalT5NJRP36Df_w_ITxE9-sAFvcqjXuEbunsMbozrI_on6DlaYMfjhcJFherK7HFoMegelWbJJZb_L0QWdneBsYWj1O3M049rLb5YgpM8Pxs1MPz_e4lTMfrZZEX85LlOk_nAteIsOunaNI_HZ8M7PpaB1tCtpbbWlAWyyAQPBSgPzzwulKHYUxIoDTrxir2VexqkYSS-tLTvhsoqUXIQ-JzFVPyDLWyRaZfICy4BCff1Upz8LIhk5QI7vNYJJ4yxbsWegtCjJYVcEdUJjyERbD-5vpNGlXrbyFnt_KRqpHRzQUds-snfGgm3Mj7falKDZ1YTU0tXUCj0ZeTqD9g_TNOhtHYQscHurZnHEAK79OuhY52yhfVdmYNg6EL7gziQAu9aYbBQphjH5HpRWFoIIj1qXc9BYMUixIK4npe6fL-5RAuc0iyLRQcaHlDYNDJD0eyi7REKfcgFwkICOBj8z_cJKyX_0D7Ct2rdsNMOeARauWrQr-G-DCXx7Uh-AlvtGZN |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+airway+inflammation+by+quantitative+Th1%2FTh2+cytokine+mRNA+measurement+in+sputum+of+asthma+patients&rft.jtitle=Thorax&rft.au=Truyen%2C+E&rft.au=Coteur%2C+L&rft.au=Dilissen%2C+E&rft.au=Overbergh%2C+L&rft.date=2006-03-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=0040-6376&rft.eissn=1468-3296&rft.volume=61&rft.issue=3&rft.spage=202&rft_id=info:doi/10.1136%2Fthx.2005.052399&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4026848081 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0040-6376&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0040-6376&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0040-6376&client=summon |